Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Jan 3, 2019Alpha radiation startup eliminates 70% of cancerous tumors#CancerBuster Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid...
Nov 7, 2018Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza andTrials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Sep 5, 2018Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure CancerProceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Aug 22, 2018Israeli Oncology Company Alpha Tau is Raising FundsAlpha Tau is in the last stages of raising an investment of several tens of millions of dollars. Israeli oncology company Alpha Tau...